FR2748658B1 - Utilisation de composes du type "alpha-bloquants" notamment le moxisylyte et/ou ses derives pour le traitement de dysfonctionnements erectiles par voie transmucosale balanique - Google Patents

Utilisation de composes du type "alpha-bloquants" notamment le moxisylyte et/ou ses derives pour le traitement de dysfonctionnements erectiles par voie transmucosale balanique

Info

Publication number
FR2748658B1
FR2748658B1 FR9606105A FR9606105A FR2748658B1 FR 2748658 B1 FR2748658 B1 FR 2748658B1 FR 9606105 A FR9606105 A FR 9606105A FR 9606105 A FR9606105 A FR 9606105A FR 2748658 B1 FR2748658 B1 FR 2748658B1
Authority
FR
France
Prior art keywords
moxisylyte
balan
alpha
derivatives
blocking
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9606105A
Other languages
English (en)
Other versions
FR2748658A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotec Centre SA
Original Assignee
Biotec Centre SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotec Centre SA filed Critical Biotec Centre SA
Priority to FR9606105A priority Critical patent/FR2748658B1/fr
Priority to TR1998/02324T priority patent/TR199802324T2/xx
Priority to EP97924075A priority patent/EP0906093A1/fr
Priority to PCT/FR1997/000837 priority patent/WO1997042946A1/fr
Priority to AU29662/97A priority patent/AU2966297A/en
Priority to CN 97196485 priority patent/CN1225581A/zh
Publication of FR2748658A1 publication Critical patent/FR2748658A1/fr
Application granted granted Critical
Publication of FR2748658B1 publication Critical patent/FR2748658B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/41—Devices for promoting penis erection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Reproductive Health (AREA)
  • Nursing (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR9606105A 1996-05-15 1996-05-15 Utilisation de composes du type "alpha-bloquants" notamment le moxisylyte et/ou ses derives pour le traitement de dysfonctionnements erectiles par voie transmucosale balanique Expired - Fee Related FR2748658B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR9606105A FR2748658B1 (fr) 1996-05-15 1996-05-15 Utilisation de composes du type "alpha-bloquants" notamment le moxisylyte et/ou ses derives pour le traitement de dysfonctionnements erectiles par voie transmucosale balanique
TR1998/02324T TR199802324T2 (xx) 1996-05-15 1997-05-13 Penis ereksiyon fonksiyonu bozukluğu tedavisi için alfa bloke ajanlarının ve özellikle de moksisilit ve/veya türevlerinin balanik transmukoza rotası üzerinden kullanımı.
EP97924075A EP0906093A1 (fr) 1996-05-15 1997-05-13 Alpha-bloquants (par exemple le moxisylyte et/ou ses derives) pour le traitement des dysfonctionnements erectils
PCT/FR1997/000837 WO1997042946A1 (fr) 1996-05-15 1997-05-13 Alpha-bloquants (par exemple le moxisylyte et/ou ses derives) pour le traitement des dysfonctionnements erectils
AU29662/97A AU2966297A (en) 1996-05-15 1997-05-13 Alpha blockers (e.g. moxisylyte and/or derivatives thereof) for treating erectile dysfunction
CN 97196485 CN1225581A (zh) 1996-05-15 1997-05-13 α阻断剂的应用,尤其是百里胺和/或其衍生物通过龟头透粘膜途径治疗阴茎勃起功能障碍

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9606105A FR2748658B1 (fr) 1996-05-15 1996-05-15 Utilisation de composes du type "alpha-bloquants" notamment le moxisylyte et/ou ses derives pour le traitement de dysfonctionnements erectiles par voie transmucosale balanique

Publications (2)

Publication Number Publication Date
FR2748658A1 FR2748658A1 (fr) 1997-11-21
FR2748658B1 true FR2748658B1 (fr) 2000-08-18

Family

ID=9492189

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9606105A Expired - Fee Related FR2748658B1 (fr) 1996-05-15 1996-05-15 Utilisation de composes du type "alpha-bloquants" notamment le moxisylyte et/ou ses derives pour le traitement de dysfonctionnements erectiles par voie transmucosale balanique

Country Status (6)

Country Link
EP (1) EP0906093A1 (fr)
CN (1) CN1225581A (fr)
AU (1) AU2966297A (fr)
FR (1) FR2748658B1 (fr)
TR (1) TR199802324T2 (fr)
WO (1) WO1997042946A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6469065B1 (en) 1996-02-02 2002-10-22 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist, compositions and methods of use
US7087240B1 (en) 1998-06-25 2006-08-08 Lavipharm Laboratories Inc. Device and method for the treatment of erectile dysfunction
NZ509031A (en) * 1998-06-25 2002-10-25 Lavipharm Lab Inc A disk formed from a filmogenic polymer carrying a therapeutic agent selected from a stabiliser, a solubiliser, an enhancer and a plasticiser
WO2018073821A1 (fr) * 2016-10-18 2018-04-26 Vasolead (2012) Ltd. Compositions et méthodes de traitement de la dysérection

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801587A (en) * 1987-03-02 1989-01-31 Gene Voss Impotence ointment
US5256652A (en) * 1987-11-12 1993-10-26 Pharmedic Co. Topical compositions and methods for treatment of male impotence
FR2666507A1 (fr) * 1990-09-07 1992-03-13 Sarget Lab Compositions pharmaceutiques pour l'administration topique de moxisylyte et de desacetyl moxisylyte et leurs utilisations en therapeutique.
BR9203277A (pt) * 1992-08-21 1994-03-01 Cesar Roberto Dias Nahoum Utilizaccao de drogas eretogenicas e respectivas metodologias de aplicacao
US5565466A (en) * 1993-08-13 1996-10-15 Zonagen, Inc. Methods for modulating the human sexual response
US5741511A (en) * 1995-04-12 1998-04-21 Sam Yang Co., Ltd. Transdermal drug delivery device for treating erectile dysfunction

Also Published As

Publication number Publication date
TR199802324T2 (xx) 2001-01-22
FR2748658A1 (fr) 1997-11-21
AU2966297A (en) 1997-12-05
EP0906093A1 (fr) 1999-04-07
CN1225581A (zh) 1999-08-11
WO1997042946A1 (fr) 1997-11-20

Similar Documents

Publication Publication Date Title
FR2624720B1 (fr) Implant pour dispositif d'osteosynthese, notamment du rachis
FR07C0046I2 (fr) Beta-l-2'-desoxy-nucleosides pour le traitement de l'hepatite b
DE69731674T8 (de) Silencieux d'aspiration pour compresseur
FR2744442B1 (fr) Preparation du 1,1,1,3,3-pentachlorobutane et du 1,1,1,3,3,-pentafluorobutane
FR2656214B1 (fr) Cadre dynamique d'osteosynthese du rachis.
OA07365A (fr) Nouvelles compositions pour la révélation et l'inhibition de la plaque dentaire.
MA24332A1 (fr) Utilisation de 1-hydroxy-2- pyridones pour le traitement d'infections de la peau
ATE347372T1 (de) Vakzine zur behandlung von mycosen
FR2695997B1 (fr) Système gyroscopique pour le mesurage d'angles.
FR2748658B1 (fr) Utilisation de composes du type "alpha-bloquants" notamment le moxisylyte et/ou ses derives pour le traitement de dysfonctionnements erectiles par voie transmucosale balanique
FR2692574B1 (fr) Derives hydroxy-4 benzenethio, leur preparation ainsi que leur utilisation pour la preparation de derives aminoalkoxybenzenesulfonyles.
DE69735417D1 (de) 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen
FR2797442B1 (fr) Derives acetamido de calixarenes, leur preparation et leur utilisation pour l'extraction du strontium
DZ1988A1 (fr) Thérapie de combinaison pour le traitement de l'hiv.
NO982105L (no) Nye mellomprodukter og deres anvendelse for fremstilling av N,N'-broslÕtte bisindolylmaleimider
DE69710305D1 (de) Derivate von 4-Vinyl-4'-alpha-hydroxyethyl-biphenyl
FR2707571B1 (fr) Ensemble van-box agence pour le transport et/ou l'hébergement des chevaux.
FR2666228B1 (fr) Composition pour le traitement des surcharges ponderales et/ou de la cellulite.
IT1239946B (it) Procedimento per la sintesi degli acidi 5-acilossi e 5-alcossi-2,3-diidro-4,6,7-trimetil-2-(rs)-benzofuranacetici
FI900835A0 (fi) Taetning med reglerbar diameter.
FR2657005B1 (fr) Systeme d'enclouage pour le traitement des fractures notamment du type cervico-trochanteriennes et pertrochanteriennes.
MA24078A1 (fr) Procede pour l'utilisation de derives de tetrahydroisoquinoleine
FR2752682B1 (fr) Perfectionnements pour des vetements et sous-vetements
FR2652899B1 (fr) Appareillage pour la determination de la nature et de l'activite des tamis moleculaires.
FR2745719B1 (fr) Composition pour le traitement d'affections cutanees

Legal Events

Date Code Title Description
TP Transmission of property
TP Transmission of property
TP Transmission of property

Free format text: BO 98/29 PAGES: 231 IL Y A LIEU DE REMPLACER: LA NATURE DE I INSCRIPTION TRANSMISSION TOTALE DE PROPRIETE PAR: TRANSMISSION PARTIELLE DE PROPRIETE.

ST Notification of lapse

Effective date: 20110131